Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: Possible role in adverse reactions

被引:18
作者
Beck, O [1 ]
Helander, A
Karlson-Stiber, C
Stephansson, N
机构
[1] Karolinska Hosp, Dept Clin Pharmacol, S-17176 Stockholm, Sweden
[2] St Gorans Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Karolinska Hosp, Swedish Poisons Informat Ctr, S-10401 Stockholm, Sweden
关键词
D O I
10.1093/jat/22.1.45
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The use of mushrooms containing the hallucinogenic substance psilocybin for intentional intoxication is relatively common. Occasionally, this results in adverse reactions with typical tachycardia that is not evidently caused by psilocybin. This study demonstrates the presence of phenylethylamine in the species Psilocybe semilanceata using gas chromatography-mass spectrometry and shows that the amount of this substance may vary much more than that of psilocybin. The highest amount of phenylethylamine (146 μg/g wet weight) was observed in mushrooms from a case of three young men hospitalized because of adverse reactions. Comparison of the symptoms observed in clinical cases of magic mushroom intoxication with those after intake of pure psilocybin or phenylethylamine suggests that phenylethylamine might have a role in the development of adverse reactions to Psilocybe mushroom intake.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 26 条
[1]   PSYCHOACTIVE MUSHROOM USE IN KOH SAMUI AND KOH PHA-NGAN, THAILAND [J].
ALLEN, JW ;
MERLIN, MD .
JOURNAL OF ETHNOPHARMACOLOGY, 1992, 35 (03) :205-228
[2]   THE FUNCTIONAL-ROLE OF MONOAMINE OXIDASE-A AND OXIDASE-B IN THE MAMMALIAN CENTRAL-NERVOUS-SYSTEM [J].
BERRY, MD ;
JUORIO, AV ;
PATERSON, IA .
PROGRESS IN NEUROBIOLOGY, 1994, 42 (03) :375-391
[3]   IDENTIFICATION AND SIGNIFICANCE OF 2-PHENYLETHYLAMINE IN FOODS [J].
CHAYTOR, JP ;
CRATHORNE, B ;
SAXBY, MJ .
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 1975, 26 (05) :593-598
[4]  
Cuomo M J, 1994, J Am Coll Health, V42, P271
[5]   EVIDENCE FOR 5-HT2 INVOLVEMENT IN THE MECHANISM OF ACTION OF HALLUCINOGENIC AGENTS [J].
GLENNON, RA ;
TITELER, M ;
MCKENNEY, JD .
LIFE SCIENCES, 1984, 35 (25) :2505-2511
[6]   SEROTONIN RECEPTOR BLOCKADE POTENTIATES BEHAVIORAL-EFFECTS OF BETA-PHENYLETHYLAMINE [J].
GOUDIE, AJ ;
BUCKLAND, C .
NEUROPHARMACOLOGY, 1982, 21 (12) :1267-1272
[7]   COMPARISON OF 3 PSYCHOTROPIC-DRUGS (PSILOCYBIN, JB-329, AND IT-290) IN VOLUNTEER SUBJECTS [J].
HOLLISTER, LE ;
PRUSMACK, JJ ;
PAULSEN, JA ;
ROSENQUIST, N .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1960, 131 (05) :428-434
[8]   COMPARISON OF THE REACTIONS INDUCED BY PSILOCYBIN AND LSD-25 IN MAN [J].
ISBELL, H .
PSYCHOPHARMACOLOGIA, 1959, 1 (01) :29-38
[9]   FATE OF PSILOCIN IN RAT [J].
KALBERER, F ;
RUTSCHMANN, J ;
KREIS, W .
BIOCHEMICAL PHARMACOLOGY, 1962, 11 (APR) :261-&
[10]  
Lassen J F, 1992, Ugeskr Laeger, V154, P2678